A carregar...
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
BACKGROUND AND OBJECTIVES: Nephrolithiasis is a common health problem in autosomal dominant polycystic kidney disease (ADPKD) and significantly contributes to patient morbidity. Recently, Tolvaptan has been introduced for the treatment of ADPKD, but whether it is associated with alterations of the u...
Na minha lista:
| Publicado no: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Nephrology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7341771/ https://ncbi.nlm.nih.gov/pubmed/32527945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.13861119 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|